세계의 바이오뱅크 장비 시장 보고서(2025년)
Biobank Equipment Global Market Report 2025
상품코드 : 1877549
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,668,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,638,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,609,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

바이오뱅크 장비 시장 규모는 최근 현저한 성장을 이루고 있습니다. 2024년의 38억 1,000만 달러에서 2025년에는 41억 8,000만 달러로 성장하고, CAGR 9.6%를 나타낼 것으로 전망되고 있습니다. 지난 수년간의 성장은 맞춤형 의료에 대한 수요 증가, 유전체 연구 투자 증가, 의약품 개발 필요성 확대, 바이오뱅크 보존 시료 이용 확대, 만성 질환 유병률 증가로 인한 것으로 보입니다.

바이오뱅크 장비 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 59억 6,000만 달러에 이르며, CAGR은 9.3%를 나타낼 전망입니다. 예측 기간 동안의 성장은 정밀의료 도입 확대, 재생의료연구에 대한 투자 증가, 줄기세포 연구 수요증대, 신약 개발분야 응용확대, 진단에 있어서의 바이오뱅킹 서비스의 필요성 증대에 기인할 것으로 예측됩니다. 예측 기간 동안 예상되는 주요 동향으로는 바이오뱅킹 기술의 진보, 극저온 보존 시스템의 혁신, 디지털 샘플 추적의 진전, 자동화 보존 시스템의 연구 개발, 클라우드 기반의 데이터 통합의 진전 등을 들 수 있습니다.

개인화된 의료에 대한 수요 증가는 앞으로 수년간 바이오뱅크 장비 시장의 성장을 가속할 것으로 예측됩니다. 맞춤형 의료는 유전자, 환경, 생활 습관에서 개인차에 따라 치료 및 예방 전략을 맞춤화하는 의료 접근법입니다. 유전체 시퀀싱 기술과 데이터 분석의 진보로 의료 제공업체는 특정 환자를 위한 보다 정밀한 진단 도구와 표적 요법을 개발할 수 있게 되어, 맞춤형 의료의 보급이 뒷받침되고 있습니다. 바이오뱅크 장비는 중요한 유전정보 및 분자정보를 포함한 생물학적 시료를 효율적으로 보존·관리함으로써 맞춤형 의료에 중요한 역할을 하며, 연구자가 개인차를 연구하고, 바이오마커를 확인하고, 환자 고유의 치료법을 개발할 수 있게 합니다. 예를 들어 미국에 본거지를 둔 병원·의료조직 '맞춤형 의료연합'에 따르면 2024년 2월 시점에서 2023년 FDA가 승인한 희소질환 환자를 위한 신규맞춤형 치료는 16건에 이르러 2022년 6건에서 증가했습니다. 이를 위해 맞춤형 의료에 대한 수요 증가가 바이오뱅크 장비 시장의 확대를 견인하고 있습니다.

바이오뱅크 장비 시장의 주요 기업은 샘플 보존 강화와 맞춤형 의료 수요 증가에 대응하기 위해 차세대 자동 보관 시스템 도입에 주력하고 있습니다. 자동 보관 시스템은 로봇 기술과 디지털 제어를 활용하고 최소한의 인위적 개입으로 생물학적 샘플을 관리, 보관, 검색하는 선진적 솔루션입니다. 이를 통해 정확한 취급, 높은 보안 및 안정적인 저장을 보장하고 샘플 무결성과 추적성을 유지할 수 있습니다. 예를 들어, 2024년 2월에는 미국에 본사를 둔 생명과학 솔루션 제공업체인 아젠타가 바이오뱅크를 위한 고밀도, 환경 친화적인 샘플 관리를 실현하는 차세대 자동 초저온 보존 솔루션 'BioArc Ultra'를 발표했습니다. 오존층 파괴계수(ODP) 제로, 지구온난화계수(GWP) 제로의 혁신적인 냉동시스템을 채용하여 -80°C에서 효율적인 자동 시료처리를 가능하게 합니다. BioArc Ultra는 기존 시스템에 비해 전력 소비와 설치 공간을 대폭 줄여 대규모 생물학적 샘플 보관 업무에서 에너지 효율과 지속가능성을 향상시킵니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Biobank equipment refers to specialized tools and systems designed for the collection, processing, and preservation of biological samples under controlled conditions to maintain their long-term integrity. It enables accurate and efficient sample management, ensuring high-quality samples for future research and analysis. Biobank equipment improves data reliability and traceability, supporting consistent and reproducible scientific results.

The primary product types of biobank equipment include cryogenic storage systems and alarm and monitoring systems. Cryogenic storage systems are specialized units used to preserve biological samples at extremely low temperatures, ensuring their long-term stability and integrity. The sample types include blood products, human tissue, umbilical cord blood stem cells, deoxyribonucleic acid (DNA), and cell lines, and the storage systems include automated biobanking systems, manual biobanking systems, hybrid biobanking systems, modular storage systems, and compact storage systems. It is utilized in various applications such as regenerative medicine, life science research, clinical research, and others and is employed by multiple end-users including biobanks and biorepositories, pharmaceutical and biotechnology companies, academic and research institutions, and hospital and diagnostic centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers' margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The biobank equipment market research report is one of a series of new reports from The Business Research Company that provides biobank equipment market statistics, including biobank equipment industry global market size, regional shares, competitors with a biobank equipment market share, detailed biobank equipment market segments, market trends and opportunities, and any further data you may need to thrive in the biobank equipment industry. The biobank equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The biobank equipment market size has grown strongly in recent years. It will grow from $3.81 billion in 2024 to $4.18 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. Growth during the historic period can be attributed to the rising demand for personalized medicine, increasing investments in genomic research, the growing need for drug development, the expanding use of biobanked specimens, and the increasing prevalence of chronic diseases.

The biobank equipment market size is expected to see strong growth in the next few years. It will grow to $5.96 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. Growth during the forecast period can be attributed to the increasing adoption of precision medicine, rising investments in regenerative medicine research, growing demand for stem cell research, expanding applications in drug discovery, and the increasing need for biobanking services in diagnostics. Major trends expected during the forecast period include advancements in biobanking technologies, innovations in cryogenic storage systems, progress in digital sample tracking, research and development in automated storage systems, and advancements in cloud-based data integration.

The rising demand for personalized medicine is anticipated to boost the growth of the biobank equipment market in the coming years. Personalized medicine is a medical approach that tailors treatment and prevention strategies according to individual variations in genes, environments, and lifestyles. The growing adoption of personalized medicine is supported by advancements in genomic sequencing technologies and data analytics, enabling healthcare providers to create more precise diagnostic tools and targeted therapies for specific patients. Biobank equipment plays a vital role in personalized medicine by efficiently preserving and managing biological samples containing essential genetic and molecular information, allowing researchers to study individual differences, identify biomarkers, and develop patient-specific therapies. For example, in February 2024, according to the Personalized Medicine Coalition, a US-based hospital and healthcare organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, an increase from six in 2022. Therefore, the rising demand for personalized medicine is driving the expansion of the biobank equipment market.

Leading companies in the biobank equipment market are focusing on introducing next-generation automated storage systems to enhance sample preservation and meet the increasing demand for personalized medicine. Automated storage systems are advanced solutions that manage, store, and retrieve biological samples with minimal human intervention, ensuring accurate handling, high security, and reliable preservation through the use of robotics and digital controls to maintain sample integrity and traceability. For instance, in February 2024, Azenta Inc., a US-based provider of life sciences solutions, launched the BioArc Ultra, a next-generation automated ultracold storage solution offering high-density, eco-friendly sample management for biorepositories. It enables efficient automated sample handling at -80°C using an innovative refrigeration system with zero ozone depletion potential and zero global warming potential. The BioArc Ultra significantly lowers power usage and space requirements compared to traditional systems, improving energy efficiency and sustainability in large-scale biological sample storage operations.

In November 2024, Standex International Corporation, a US-based industrial growth company, acquired Custom Biogenic Systems for $6.2 million. This acquisition aims to strengthen Standex International's Scientific business segment by incorporating Custom Biogenic Systems' advanced cryogenic storage and refrigeration technologies. The acquisition broadens Standex's presence in the pharmaceutical and biobank markets while expanding its technology portfolio with liquid nitrogen and controlled-rate freezer systems. Custom Biogenic Systems is a US-based manufacturer of biobank equipment.

Major players in the biobank equipment market are Thermo Fisher Scientific Inc., Merck KGaA Darmstadt Germany, Becton Dickinson and Company, Agilent Technologies Inc., Revvity Inc., PHC Holdings Corporation, QIAGEN N.V., Eppendorf SE, Tecan Group Ltd., Bio-Techne Corporation, Hamilton Company, Azenta Life Sciences Inc., Promega Corporation, BioLife Solutions Inc., Standard BioTools Inc., SPT Labtech Ltd, LabVantage Solutions Inc., Izon Science Limited, askion GmbH, Custom Biogenic Systems Inc., and Zhongke Meiling Cryogenics Co. Ltd.

North America was the largest region in the biobank equipment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in biobank equipment report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the biobank equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The biobank equipment market consists of sales of sample storage freezers, centrifuges, biospecimen tracking systems, and temperature monitoring devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biobank Equipment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biobank equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for biobank equipment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The biobank equipment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Biobank Equipment Market Characteristics

3. Biobank Equipment Market Trends And Strategies

4. Biobank Equipment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Biobank Equipment Growth Analysis And Strategic Analysis Framework

6. Biobank Equipment Market Segmentation

7. Biobank Equipment Market Regional And Country Analysis

8. Asia-Pacific Biobank Equipment Market

9. China Biobank Equipment Market

10. India Biobank Equipment Market

11. Japan Biobank Equipment Market

12. Australia Biobank Equipment Market

13. Indonesia Biobank Equipment Market

14. South Korea Biobank Equipment Market

15. Western Europe Biobank Equipment Market

16. UK Biobank Equipment Market

17. Germany Biobank Equipment Market

18. France Biobank Equipment Market

19. Italy Biobank Equipment Market

20. Spain Biobank Equipment Market

21. Eastern Europe Biobank Equipment Market

22. Russia Biobank Equipment Market

23. North America Biobank Equipment Market

24. USA Biobank Equipment Market

25. Canada Biobank Equipment Market

26. South America Biobank Equipment Market

27. Brazil Biobank Equipment Market

28. Middle East Biobank Equipment Market

29. Africa Biobank Equipment Market

30. Biobank Equipment Market Competitive Landscape And Company Profiles

31. Biobank Equipment Market Other Major And Innovative Companies

32. Global Biobank Equipment Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biobank Equipment Market

34. Recent Developments In The Biobank Equipment Market

35. Biobank Equipment Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기